However, inconsistent with these results, Yosifov et al., observed that OPN-a or OPN-b overexpressing multiple myeloma cells, have lower sensitivity to erufosine compared to the original cells, especially the OPN-a overexpressing variant [95]. This evidence concerns the gene SPP1 and plasma cell myeloma.